🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCalgary compounding pharmacies — anyone have experience?

Calgary compounding pharmacies — anyone have experience?

BethLabQueen Sat, Jan 10, 2026 at 6:55 AM 38 replies 1,386 viewsPage 1 of 8
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jan 10, 2026 at 6:55 AM#1

Two pharmacies quoted me last year, one describing itself as 503A and one as 503B, and I assumed 503B just meant bigger until both stopped within weeks of each other.

The question I want answered is what actually distinguishes 503A from 503B, in terms of what each may make and from what starting material.

I have searched first, so if this is covered somewhere point me at it and I will read it.

15 10maya_sedona, stefan_berlin, Dr.EM_Chicago and 12 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jan 10, 2026 at 8:46 AM#2

Answering the narrow version, because the broad one does not have a single answer. The shortage clause is the answer to the second question and it is a subtraction rather than an addition. Both exemptions forbid compounding something that is essentially a copy of a commercially available approved product. A product FDA has listed as in shortage is not treated as commercially available, so listing removed the objection that otherwise blocked compounding. It never created a permission; it withdrew a prohibition, which is why it evaporated the moment the supply fact changed.

14 9andrew_nyc, Dr.EndoEP, GraceAZ_72 and 11 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Jan 10, 2026 at 10:37 AM#3
Dr.ReproEndo said:
The shortage clause is the answer to the second question and it is a subtraction rather than an addition.

Agreed, and the enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured inventory and clinic contracts to unwind while a 503A makes to order.

Happy to go further on any of that.

13 8alex_tucson, kevin_tulsa, Dr.PainCLE and 10 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jan 10, 2026 at 12:28 PM#4
BethLabQueen said:
Two pharmacies quoted me last year, one describing itself as 503A and one as 503B, and I assumed 503B just meant bigger until both stopped within…

Same position here, arrived at the long way round. They are two different exemptions from the same federal requirements and they buy different things. A 503A pharmacy is regulated primarily by the state board, needs a patient-specific prescription, is exempt from CGMP, and may use a bulk substance that has a USP monograph, is a component of an approved drug, or appears on the 503A bulks list — three independent doorways. A 503B outsourcing facility registers with the FDA, is inspected on a risk basis, must comply with CGMP, may compound for office stock without a patient-specific prescription, and has one doorway to a permitted bulk substance: the 503B bulks list, or the drug shortage list.

Happy to go further on any of that.

Last edited: Jan 10, 2026 at 6:28 PM
12 7tammy_FL, Dr.LipidDallas, alex_tucson and 9 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Jan 10, 2026 at 11:27 PM#5

Clinical perspective, offered as context rather than as advice.

Compounding pharmacy licensing verification for compounded supply: before ordering, verify your pharmacy's credentials:

  1. State Board of Pharmacy license — check on your state BOP website
  2. FDA registration (for 503B) — check on fda.gov
  3. DEA registration if handling controlled substances
  4. PCAB accreditation — voluntary but demonstrates commitment to quality
  5. USP <797>/<800> compliance for sterile compounding

This takes 10 minutes of research and could save you from receiving substandard or unsafe medication.

11 6dan_philly, MeganSA_TX, LarryQC_SD and 8 others
Reply Quote Save Share Report
1238

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register